Intelligent Bio Solutions to Showcase Innovative Drug Testing Solutions at NDASA Conference
New York, NY – March 28, 2025 – Intelligent Bio Solutions Inc. (INBS), a pioneering medical technology company specializing in the development and commercialization of intelligent, rapid, and non-invasive testing solutions, is thrilled to announce its participation as a gold sponsor at the 2025 National Drug and Alcohol Screening Association (NDASA) Conference and Trade Show. The event will take place from April 1 – 4 in Jacksonville, Florida.
Company Executives to Present at International Symposium
Daniel Brown, Head of Clinical Affairs at Intelligent Bio Solutions, will be a featured presenter at the International Symposium on Tuesday, April 1, at 1:00 PM. Brown will discuss the latest advancements in drug testing technology and how INBS’s solutions are revolutionizing the industry.
Groundbreaking Technologies from Intelligent Bio Solutions
Intelligent Bio Solutions’ innovative testing solutions are designed to deliver accurate, rapid results in a non-invasive manner. The Company’s offerings include:
- Saliva Testing: INBS’s saliva testing technology allows for quick and easy drug screening, eliminating the need for invasive procedures such as urine tests.
- Point-of-Care Testing: INBS’s point-of-care testing solutions enable real-time results, making it easier for organizations to implement and manage their drug testing programs.
- Advanced Analytics: INBS’s advanced analytics capabilities provide valuable insights and trends, enabling better decision-making and improved overall program effectiveness.
Impact on Individuals and Communities
The participation of Intelligent Bio Solutions at the NDASA Conference signifies a significant stride forward in the drug testing industry. This development will:
- Improve Accessibility: The non-invasive nature of INBS’s testing solutions will make drug testing more accessible and convenient for individuals and organizations.
- Enhance Privacy: Saliva testing eliminates the need for invasive procedures, providing a more private testing experience.
- Reduce Costs: The point-of-care testing solutions offered by INBS can help organizations save costs by reducing the need for lab testing and the associated transportation costs.
Global Implications
Beyond the individual and community level, the advancements in drug testing technology by Intelligent Bio Solutions will have far-reaching implications:
- Workplaces: The adoption of non-invasive, rapid drug testing solutions will streamline workplace drug testing programs, improving efficiency and reducing costs.
- Healthcare: INBS’s testing solutions can be utilized in various healthcare settings to ensure patient safety and improve overall care.
- Law Enforcement: Rapid, non-invasive drug testing can aid law enforcement agencies in identifying substance abuse and addressing related issues more effectively.
Conclusion
Intelligent Bio Solutions’ participation as a gold sponsor at the NDASA Conference represents a significant milestone in the drug testing industry. With its innovative, non-invasive testing solutions, INBS is poised to make a positive impact on individuals, communities, and the world at large. As we look forward to Daniel Brown’s presentation at the International Symposium, we can expect to gain valuable insights into the latest advancements in drug testing technology and how they will shape the future of this essential field.
Stay tuned for further updates on Intelligent Bio Solutions and its groundbreaking solutions. Together, we can create a safer, healthier world.
